Recital 7, Regulation (EU) 2022/2340

In force

On 14 March 2018, the Authority adopted a scientific opinion on the safety of green tea catechins [EFSA Journal 2018;16(4):5239.]. The Authority concluded in that opinion that catechins from green tea infusions prepared in a traditional way, and reconstituted drinks with an equivalent composition to traditional green tea infusions, are in general considered to be safe according to the presumption of safety approach, provided the intake corresponds to reported intakes in Member States. The mean daily intake of (-)-epigallocatechin-3-gallate resulting from the consumption of green tea infusions ranges from 90 to 300 mg/day.